These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2453610)
1. Detection of N-terminally extended substance P but not of substance P in human cerebrospinal fluid: quantitation with HPLC-radioimmunoassay. Toresson G; Brodin E; Wahlström A; Bertilsson L J Neurochem; 1988 Jun; 50(6):1701-7. PubMed ID: 2453610 [TBL] [Abstract][Full Text] [Related]
2. Multiple molecular forms of tachykinins in rat spinal cord: a study comparing different extraction methods. Brodin E; Rosén A; Theodorsson E; Jonczyk A; Sandberg BE; Brodin K Regul Pept; 1994 Jul; 52(2):97-110. PubMed ID: 7526421 [TBL] [Abstract][Full Text] [Related]
3. N-terminally extended substance P is released together with substance P from rat spinal cord. Toresson G; de las Carreras C; Bertilsson L; Brodin E Regul Pept; 1990 Mar; 28(1):39-46. PubMed ID: 1691519 [TBL] [Abstract][Full Text] [Related]
4. Substance P-like immunoreactivity in human cerebrospinal fluid. Higa T; Wood G; Desiderio DM Int J Pept Protein Res; 1989 Jun; 33(6):446-51. PubMed ID: 2476411 [TBL] [Abstract][Full Text] [Related]
5. Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A. Brodin E; Lindefors N; Dalsgaard CJ; Theodorsson-Norheim E; Rosell S Regul Pept; 1986 Feb; 13(3-4):253-72. PubMed ID: 2422706 [TBL] [Abstract][Full Text] [Related]
6. N-terminally extended tachykinins in human cerebrospinal fluid. Toresson G; Brodin E; Bertilsson L Regul Pept; 1993 Jul; 46(1-2):357-9. PubMed ID: 7692536 [TBL] [Abstract][Full Text] [Related]
7. Quantitation of N-terminally extended tachykinins in cerebrospinal fluid from healthy subjects. Toresson G; Brodin E; de las Carreras C; Nordin C; Zachau AC; Bertilsson L Regul Pept; 1994 Feb; 50(2):185-91. PubMed ID: 7514800 [TBL] [Abstract][Full Text] [Related]
8. Neuropeptide K is present in human cerebrospinal fluid. Toresson G; de las Carreras C; Brodin E; Bertilsson L Life Sci; 1990; 46(23):1707-14. PubMed ID: 2162461 [TBL] [Abstract][Full Text] [Related]
9. Optimization of high-performance liquid chromatography-radioimmunoassay protocols for the analyses of substance P and some of its metabolic fragments. Igwe OJ; Felice LJ; Seybold VS; Larson AA J Chromatogr; 1988 Nov; 432():113-26. PubMed ID: 2464606 [TBL] [Abstract][Full Text] [Related]
10. Characterization of substance P-like immunoreactivity in submammalian species by high performance liquid chromatography. Lembeck F; Bernatzky G; Gamse R; Saria A Peptides; 1985; 6 Suppl 3():231-6. PubMed ID: 2421261 [TBL] [Abstract][Full Text] [Related]
11. Development of an antiserum to the midportion of substance P: applications for biochemical and anatomical studies of substance P-related peptide species in CNS tissues. Shimonaka H; Marchand JE; Connelly CS; Kream RM J Neurochem; 1992 Jul; 59(1):81-92. PubMed ID: 1377229 [TBL] [Abstract][Full Text] [Related]
12. Measurement and partial characterization of the multiple forms of neurokinin A-like immunoreactivity in carcinoid tumours. Conlon JM; Deacon CF; Richter G; Schmidt WE; Stöckmann F; Creutzfeldt W Regul Pept; 1986 Jan; 13(2):183-96. PubMed ID: 3006157 [TBL] [Abstract][Full Text] [Related]
13. Beta-endorphin-immunoreactive components in human cerebrospinal fluid. Winther Bach F; Ekman R; Jensen FM Regul Pept; 1986 Dec; 16(3-4):189-98. PubMed ID: 2951770 [TBL] [Abstract][Full Text] [Related]
14. Evidence for the existence of substance P in the prepubertal rat ovary. I. Biochemical and physiologic studies. Ojeda SR; Costa ME; Katz KH; Hersh LB Biol Reprod; 1985 Sep; 33(2):286-95. PubMed ID: 2412598 [TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization and anatomical distribution of a major form of unamidated precursor of substance P in rat brain. Marchand JE; Shimonaka H; Kream RM Brain Res; 1991 Dec; 567(2):290-305. PubMed ID: 1726313 [TBL] [Abstract][Full Text] [Related]
16. Precursor forms of substance P (SP) in nervous tissue: detection with antisera to SP, SP-Gly, and SP-Gly-Lys. Kream RM; Schoenfeld TA; Mancuso R; Clancy AN; el-Bermani W; Macrides F Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4832-6. PubMed ID: 2410906 [TBL] [Abstract][Full Text] [Related]
17. Peptide histidine isoleucine-like immunoreactivity release from the rat gastric fundus. Currò D; Preziosi P; Ragazzoni E; Ciabattoni G Br J Pharmacol; 1994 Oct; 113(2):541-9. PubMed ID: 7834206 [TBL] [Abstract][Full Text] [Related]
18. Reversed-phase high-performance liquid chromatography combined with tandem mass spectrometry in studies of a substance P-converting enzyme from human cerebrospinal fluid. Eriksson U; Andrén PE; Caprioli RM; Nyberg F J Chromatogr A; 1996 Aug; 743(1):213-20. PubMed ID: 8817884 [TBL] [Abstract][Full Text] [Related]
19. Expression of substance P and its precursor forms in vagal, tracheal, and lung tissues of the guinea pig. Kream RM; Marchand JE; O'Connor ST; Bloomquist EI Am J Physiol; 1994 Dec; 267(6 Pt 1):L807-14. PubMed ID: 7528984 [TBL] [Abstract][Full Text] [Related]
20. Neurokinin B in a human pheochromocytoma measured with a specific radioimmunoassay. Kage R; Conlon JM Peptides; 1989; 10(3):713-6. PubMed ID: 2780425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]